GPR119 AGONIST

PROBLEM TO BE SOLVED: To provide a novel therapeutic agent for diabetes.SOLUTION: Provided is a compound represented by the specified general formula (II) or a salt thereof, which is a GPR119 agonist. (In formula (II), Arrepresents a phenyl group or the like which may have a substituent selected fro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ENDO TAKESHI, TAKAHASHI RIE, KUNIGAMI TOSHIHIRO
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	ENDO TAKESHI TAKAHASHI RIE KUNIGAMI TOSHIHIRO
description	PROBLEM TO BE SOLVED: To provide a novel therapeutic agent for diabetes.SOLUTION: Provided is a compound represented by the specified general formula (II) or a salt thereof, which is a GPR119 agonist. (In formula (II), Arrepresents a phenyl group or the like which may have a substituent selected from a halogen atom, a nitro group, a cyano group, a Calkyl group, an alkoxycarbonyl group with a Calkoxy, and the like; Rrepresents a Calkyl group; Rrepresents a Calkyl group; and Rand Reach represent a hydrogen atom, a halogen atom, or the like.)
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2014001144A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2014001144A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2014001144A3</originalsourceid><addsrcrecordid>eNrjZOBzDwgyNLRUcHT39_MMDuFhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGhiYGBoaGJiaOxkQpAgDk_x0E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GPR119 AGONIST</title><source>esp@cenet</source><creator>ENDO TAKESHI ; TAKAHASHI RIE ; KUNIGAMI TOSHIHIRO</creator><creatorcontrib>ENDO TAKESHI ; TAKAHASHI RIE ; KUNIGAMI TOSHIHIRO</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a novel therapeutic agent for diabetes.SOLUTION: Provided is a compound represented by the specified general formula (II) or a salt thereof, which is a GPR119 agonist. (In formula (II), Arrepresents a phenyl group or the like which may have a substituent selected from a halogen atom, a nitro group, a cyano group, a Calkyl group, an alkoxycarbonyl group with a Calkoxy, and the like; Rrepresents a Calkyl group; Rrepresents a Calkyl group; and Rand Reach represent a hydrogen atom, a halogen atom, or the like.)</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140109&DB=EPODOC&CC=JP&NR=2014001144A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140109&DB=EPODOC&CC=JP&NR=2014001144A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ENDO TAKESHI</creatorcontrib><creatorcontrib>TAKAHASHI RIE</creatorcontrib><creatorcontrib>KUNIGAMI TOSHIHIRO</creatorcontrib><title>GPR119 AGONIST</title><description>PROBLEM TO BE SOLVED: To provide a novel therapeutic agent for diabetes.SOLUTION: Provided is a compound represented by the specified general formula (II) or a salt thereof, which is a GPR119 agonist. (In formula (II), Arrepresents a phenyl group or the like which may have a substituent selected from a halogen atom, a nitro group, a cyano group, a Calkyl group, an alkoxycarbonyl group with a Calkoxy, and the like; Rrepresents a Calkyl group; Rrepresents a Calkyl group; and Rand Reach represent a hydrogen atom, a halogen atom, or the like.)</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOBzDwgyNLRUcHT39_MMDuFhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGhiYGBoaGJiaOxkQpAgDk_x0E</recordid><startdate>20140109</startdate><enddate>20140109</enddate><creator>ENDO TAKESHI</creator><creator>TAKAHASHI RIE</creator><creator>KUNIGAMI TOSHIHIRO</creator><scope>EVB</scope></search><sort><creationdate>20140109</creationdate><title>GPR119 AGONIST</title><author>ENDO TAKESHI ; TAKAHASHI RIE ; KUNIGAMI TOSHIHIRO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2014001144A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ENDO TAKESHI</creatorcontrib><creatorcontrib>TAKAHASHI RIE</creatorcontrib><creatorcontrib>KUNIGAMI TOSHIHIRO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ENDO TAKESHI</au><au>TAKAHASHI RIE</au><au>KUNIGAMI TOSHIHIRO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GPR119 AGONIST</title><date>2014-01-09</date><risdate>2014</risdate><abstract>PROBLEM TO BE SOLVED: To provide a novel therapeutic agent for diabetes.SOLUTION: Provided is a compound represented by the specified general formula (II) or a salt thereof, which is a GPR119 agonist. (In formula (II), Arrepresents a phenyl group or the like which may have a substituent selected from a halogen atom, a nitro group, a cyano group, a Calkyl group, an alkoxycarbonyl group with a Calkoxy, and the like; Rrepresents a Calkyl group; Rrepresents a Calkyl group; and Rand Reach represent a hydrogen atom, a halogen atom, or the like.)</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_JP2014001144A
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	GPR119 AGONIST
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T07%3A30%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ENDO%20TAKESHI&rft.date=2014-01-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2014001144A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true